Lekang Jiarun

BiotechnologyAngelHangzhou, China

Latest round

Angel

Last raised

May 2024

Total raised

Undisclosed

Investors

2

About Lekang Jiarun

Founded in 2022 and based in Hangzhou, China, Lekang Jiarun is a biotech company that focuses on the research and development of anti-tumor drugs. Dawei Chen, the company’s chief scientist, founded Baiintaihe and served as the dean of the School of Pharmacy at Shenyang Pharmaceutical University. The company has anti-tumor platinum prodrug technology platform, nucleic acid drug delivery system technology platform, hypoglycemic peptide non-injection drug delivery technology platform and other drug research and development platforms. Its main products include divalent platinum drugs and quadrivalent platinum prodrugs. The company also provides CRO business services and generic drug research and development services. The company’s revenue is generated by providing anti-tumor drugs.

Who invested in Lekang Jiarun

2 investors across 1 round

See all investors in Lekang Jiarun

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Angel

    May 22, 2024

    Amount

    Undisclosed

    Investors

    Locked

Questions about Lekang Jiarun

Who invested in Lekang Jiarun?

Lekang Jiarun has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Lekang Jiarun raised?

Lekang Jiarun has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Lekang Jiarun last raise money?

Lekang Jiarun's most recent round on record is a Angel, in May 2024.

What does Lekang Jiarun do?

Founded in 2022 and based in Hangzhou, China, Lekang Jiarun is a biotech company that focuses on the research and development of anti-tumor drugs.

Where is Lekang Jiarun headquartered?

Lekang Jiarun is headquartered in Hangzhou, China.

Which VCs invest in companies like Lekang Jiarun?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Lekang Jiarun's stage. Their profiles are linked below.

Raising like Lekang Jiarun? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.